Abstract Library

#1210 Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study.

Introduction: P-CT can evaluate inner perfusional features of primary and metastatic PanNETs; preliminary evidences suggest its potential role in predicting early response to anti-angiogenic therapies. Perfusional modifications induced by E in LM are not completely understood.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: De Robertis R

Authors: Ortolani S, De Robertis R, D'Onofrio M, Cingarlini S, Crosara S,

Keywords: perfusion CT, pancreas neuroendocrine tumor, everolimus,

#999 Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study

Introduction: Criteria other than RECIST are not validated for evaluation of response during treatment in pancreatic neuroendocrine tumors (pNETs). Preliminary evidence favors antiangiogenic properties of E.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Cingarlini S

Authors: Ortolani S, De Robertis R, Cingarlini S, D'Onofrio M, Crosara S,

Keywords: everolimus, pNET, P-CT,